St. Jude Medical (STJ -3.5%) drops after the FDA orders a review of its Riata defibrillator...

|About: St. Jude Medical, Inc. (STJ)|By:, SA News Editor

St. Jude Medical (STJ -3.5%) drops after the FDA orders a review of its Riata defibrillator leads. The agency recommends patients who have defibrillators with Riata leads should have x-rays or other imaging scans to check for abnormalities in the insulation surrounding the lead. STJ recalled the leads back in Nov. 2011; FDA says routine imaging may detect previously unrecognized abnormalities.